Net profit of Genomic Valley Biotech rose 650.00% to Rs 0.15 crore in the quarter ended September 2024 as against Rs 0.02 crore during the previous quarter ended September 2023. Sales rose 200.00% to Rs 0.21 crore in the quarter ended September 2024 as against Rs 0.07 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended |
| Sep. 2024 | Sep. 2023 | % Var. |
| Sales | 0.21 | 0.07 | 200 |
| OPM % | 66.67 | 28.57 | - |
| PBDT | 0.15 | 0.02 | 650 |
| PBT | 0.15 | 0.02 | 650 |
| NP | 0.15 | 0.02 | 650 |